TUBERCULOSIS, MDR

Clinical trials for TUBERCULOSIS, MDR explained in plain language.

Never miss a new study

Get alerted when new TUBERCULOSIS, MDR trials appear

Sign up with your email to follow new studies for TUBERCULOSIS, MDR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

New hope for Drug-Resistant TB: shorter, safer treatment on the horizon?

Disease control Recruiting now

This study tests whether a shorter treatment regimen (13-24 weeks) using a combination of drugs (bedaquiline, linezolid, pretomanid, and moxifloxacin) works as well as the standard longer treatment for people with a type of drug-resistant tuberculosis. About 400 adults with fluor…

Matched conditions: TUBERCULOSIS, MDR

Phase: PHASE2, PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC

TUBERCULOSIS, MDR

Get alerted when new TUBERCULOSIS, MDR trials appear

New hope for Drug-Resistant TB: shorter, safer treatment on the horizon?